Tailoring Treatment for Patients With HR+/HER2- METASTATIC BREAST CANCER: Examining the Role of Current and Emerging Endocrine Therapies

Meeting Date: 
Tuesday, June 17, 2025

Time:
8:00-9:00 AM ET

Location:
Goshen Health
Goshen, IN

Faculty Speaker:
Erika P. Hamilton, MD

Pin It on Pinterest

Scroll to Top

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers